<DOC>
	<DOCNO>NCT00537719</DOCNO>
	<brief_summary>This study use scintigraphy technique measure gastric empty rate liquid solid food baseline administration GSK716155 placebo .</brief_summary>
	<brief_title>Scintigraphy Study Assess Gastric Emptying Healthy Subjects Given GSK716155 Placebo .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>rGLP-1 protein</mesh_term>
	<criteria>Healthy men woman , age 18 65 , Body Mass Index ( BMI ) 20 32 . If female , subject must capable child . Subjects must use tobacco , nicotine , illegal drug abuse , must take caffeine alcohol 24 hour dose set scintigraphy procedure . Subjects may HIV , hepatitis , elevate fast blood sugar level , high blood pressure , heart , lung , liver , gall bladder , gastrointestinal , pancreatic , kidney disease , untreated thyroid disease . Subjects must history alcohol abuse , must take prescription nonprescription drug within 7 day Day 1 Day 8 study , must previous exposure GLP1 mimetic exenatide . Prior radiation exposure must meet certain limit order participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>healthy</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>glucagon-like peptide 1</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>scintigraphy</keyword>
	<keyword>radiation</keyword>
	<keyword>albiglutide</keyword>
</DOC>